Kim HJ - Search Results

1

ZSTK474, a PI3K inhibitor, suppresses proliferation and sensitizes human pancreatic adenocarcinoma cells to gemcitabine.

Duong HQ, Kim HJ, Kang HJ, Seong YS, Bae I. Duong HQ, et al. Among authors: kim hj. Oncol Rep. 2012 Jan;27(1):182-8. doi: 10.3892/or.2011.1503. Epub 2011 Oct 12. Oncol Rep. 2012. PMID: 21993922 Free PMC article.

2

Inhibition of cell proliferation by a resveratrol analog in human pancreatic and breast cancer cells.

Hong YB, Kang HJ, Kim HJ, Rosen EM, Dakshanamurthy S, Rondanin R, Baruchello R, Grisolia G, Daniele S, Bae I. Hong YB, et al. Among authors: kim hj. Exp Mol Med. 2009 Mar 31;41(3):151-60. doi: 10.3858/emm.2009.41.3.018. Exp Mol Med. 2009. PMID: 19293634 Free PMC article.

3

Inhibition of constitutively activated phosphoinositide 3-kinase/AKT pathway enhances antitumor activity of chemotherapeutic agents in breast cancer susceptibility gene 1-defective breast cancer cells.

Yi YW, Kang HJ, Kim HJ, Hwang JS, Wang A, Bae I. Yi YW, et al. Among authors: kim hj. Mol Carcinog. 2013 Sep;52(9):667-75. doi: 10.1002/mc.21905. Epub 2012 Apr 4. Mol Carcinog. 2013. PMID: 22488590 Free PMC article.

4

Aldehyde dehydrogenase 1A1 confers intrinsic and acquired resistance to gemcitabine in human pancreatic adenocarcinoma MIA PaCa-2 cells.

Duong HQ, Hwang JS, Kim HJ, Kang HJ, Seong YS, Bae I. Duong HQ, et al. Among authors: kim hj. Int J Oncol. 2012 Sep;41(3):855-61. doi: 10.3892/ijo.2012.1516. Epub 2012 Jun 12. Int J Oncol. 2012. PMID: 22710732 Free PMC article.

5

BML-275, an AMPK inhibitor, induces DNA damage, G2/M arrest and apoptosis in human pancreatic cancer cells.

Duong HQ, Hwang JS, Kim HJ, Seong YS, Bae I. Duong HQ, et al. Among authors: kim hj. Int J Oncol. 2012 Dec;41(6):2227-36. doi: 10.3892/ijo.2012.1672. Epub 2012 Oct 17. Int J Oncol. 2012. PMID: 23076030 Free PMC article.

6

Inhibition of the PI3K/AKT pathway potentiates cytotoxicity of EGFR kinase inhibitors in triple-negative breast cancer cells.

Yi YW, Hong W, Kang HJ, Kim HJ, Zhao W, Wang A, Seong YS, Bae I. Yi YW, et al. Among authors: kim hj. J Cell Mol Med. 2013 May;17(5):648-56. doi: 10.1111/jcmm.12046. Epub 2013 Apr 20. J Cell Mol Med. 2013. PMID: 23601074 Free PMC article.

7

BRCA1 negatively regulates IGF-1 expression through an estrogen-responsive element-like site.

Kang HJ, Yi YW, Kim HJ, Hong YB, Seong YS, Bae I. Kang HJ, et al. Among authors: kim hj. Cell Death Dis. 2012 Jun 28;3(6):e336. doi: 10.1038/cddis.2012.78. Cell Death Dis. 2012. PMID: 22739988 Free PMC article.

8

BRCA1 modulates xenobiotic stress-inducible gene expression by interacting with ARNT in human breast cancer cells.

Kang HJ, Kim HJ, Kim SK, Barouki R, Cho CH, Khanna KK, Rosen EM, Bae I. Kang HJ, et al. Among authors: kim hj, kim sk. J Biol Chem. 2006 May 26;281(21):14654-62. doi: 10.1074/jbc.M601613200. Epub 2006 Mar 27. J Biol Chem. 2006. PMID: 16567799 Free article.

9

BRCA1 modulates sensitivity to 5F-203 by regulating xenobiotic stress-inducible protein levels and EROD activity.

Kang HJ, Kim HJ, Kwon SH, Kang BD, Eling TE, Lee SH, Bae I. Kang HJ, et al. Among authors: kim hj. Cancer Chemother Pharmacol. 2008 Sep;62(4):689-97. doi: 10.1007/s00280-007-0657-7. Epub 2007 Dec 12. Cancer Chemother Pharmacol. 2008. PMID: 18074135

10

BRCA1 transcriptional activity is enhanced by interactions between its AD1 domain and AhR.

Kang HJ, Kim HJ, Cho CH, Hu Y, Li R, Bae I. Kang HJ, et al. Among authors: kim hj. Cancer Chemother Pharmacol. 2008 Nov;62(6):965-75. doi: 10.1007/s00280-008-0686-x. Epub 2008 Feb 8. Cancer Chemother Pharmacol. 2008. PMID: 18259752 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,811 results

Search Page

Filters